The Centers for Medicare & Medicaid Services’ (CMS’) final rule advances policies to promote the efficient operation of the Medicaid Drug Rebate Program (MDRP).
Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Final Rule
Newsroom Homepage
Listing of Newsroom articles
Press Releases
HHS Secretary Responds to the President’s Executive Order on Drug Prices
Action announces new models and supports access to $2 generic drugs Read more about HHS Secretary Responds to the President’s Executive Order on Drug Prices
Press Releases
Biden-Harris Administration Continues Unprecedented Efforts to Increase Transparency of Nursing Home Ownership
Proposed rule would require disclosure of additional ownership and management information to shine a light on private equity ownership Administration seeking to implement Section 6101(a) of the Affordable Care Act Read more about Biden-Harris Administration Continues Unprecedented Efforts to Increase Transparency of Nursing Home Ownership
Fact Sheets
Disclosures of Ownership and Additional Disclosable Parties Information for Skilled Nursing Facilities and Nursing Facilities — Proposed Rule
On February 13, 2023, the Centers for Medicare & Medicaid Services (CMS) placed on display at the Federal Register a proposed rule that would implement portions of section 6101 of the Affordable Care Act, which require the disclosure of certain ownership, managerial, and other information regarding Read more about Disclosures of Ownership and Additional Disclosable Parties Information for Skilled Nursing Facilities and Nursing Facilities — Proposed Rule
CMS Round Up
CMS Roundup (Feb. 10, 2023)
Today, the Centers for Medicare & Medicaid Services (CMS) is providing an at-a-glance summary of news from around the agency: CMS Releases Updated Resources to Prepare for theMay 11 End of the COVID-19 Public Health Emergency and National Emergency January 30: The Biden Administration announced its Read more about CMS Roundup (Feb. 10, 2023)
Press Releases
HHS Releases Initial Guidance for Medicare Prescription Drug Inflation Rebate Program
Under President Biden’s prescription drug law, drug companies will pay rebates to the federal government for raising prescription drug prices faster than the rate of inflation Read more about HHS Releases Initial Guidance for Medicare Prescription Drug Inflation Rebate Program
Fact Sheets